Report

Global patient temperature monitoring market is projected to witness a CAGR of 7.66% during the forecast period 2024-2031, growing from USD 3.53 billion in 2023 to USD 6.37 billion in 2031. The increasing prevalence of chronic diseases and viral infections, often accompanied by fever or other physiological changes, is a significant driver behind the increasing demand for body temperature monitoring. This need arises from the necessity to monitor illness progression and treatment effectiveness. Additionally, the rise in airborne diseases, fueled by increasing air pollution levels, further increases the demand for body temperature monitoring solutions. Furthermore, the expanding geriatric population, which is more vulnerable to various medical conditions, such as influenza, pneumonia, malaria, rheumatoid arthritis, ulcerative colitis, and endocarditis, contributes positively to market growth.
Moreover, the surge in demand for remote patient monitoring (RPM) and notable advancements in healthcare services are driving market expansion. Adopting body temperature monitoring devices in commercial settings like shopping malls, schools, restaurants, theaters, and stores to mitigate infection transmission risks also drives market growth. Additionally, the increasing adoption of wearable devices that integrate with smart technology for real-time patient data collection, alongside the growing popularity of mobile health (m-health) applications, catalyzes market growth.
Biobeat, a company specializing in wearable remote monitoring solutions, revealed on March 28, 2022, that its wearable remote patient monitoring device obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for body temperature monitoring purposes.
Increasing Prevalence of Infectious Diseases
The rising occurrence of infectious diseases like swine flu, COVID-19, and ebola is causing an upsurge in body temperatures due to fever. This surge in demand for body temperature monitoring devices is exemplified by a July 2022 report from the World Health Organization (WHO). From December 27, 2021, to January 9, 2022, WHO Global Influenza Surveillance and Response System (GISRS) laboratories analyzed over 317,198 specimens from labs in 99 countries. Among these tests, 16,862 individuals tested positive for influenza viruses, with 63.7% identified as influenza A and 36.3% as influenza B. The prevalent symptoms, including fever and chills, are expected to boost the market for body temperature monitoring products. Apart from the rising geriatric population, the expansion of the pediatric population is also anticipated to be a key driver for the growth of this sector. As of July 2022, data from United Nations Projections indicated a global pediatric population (0-17 years) of 2.3 billion in 2022, with projections anticipating an increase to 2.5 billion by the conclusion of 2040. Given the ongoing increase in the pediatric population, there is an expected rise in the demand for body temperature monitoring devices in the foreseeable future.
Technological Advancements
One of the key catalysts for the growth of the global body temperature monitoring market is the ongoing progression of technology in temperature monitoring devices. These advancements encompass diverse technologies such as sensor technology, connectivity, and data analytics. The accuracy and precision of temperature measurements have notably improved due to advanced sensors and calibration techniques. This improvement is particularly crucial in healthcare settings, where even minor temperature variations hold clinical significance. Contemporary temperature monitoring devices prioritize user-friendliness and non-invasiveness. For instance, infrared thermometers offer swift and contactless readings, ensuring comfort for both patients and healthcare providers. Many of these recent devices seamlessly integrate with electronic health records (EHR) systems and telehealth platforms, streamlining the data collection and sharing process. This integration enhances healthcare professionals' capabilities in monitoring and managing patient health. The patented OmnySense device developed by Tamooz Product Design in Kfar Saba integrates a microphone to capture breath sounds. It accurately detects not just body temperature, but also respiratory rate, pulse rate, ECG, and blood oxygen levels.
Dominance of Wearable Continuous Monitoring Sensors
Wearable thermometers offer numerous benefits in healthcare and overall wellness. They provide continuous and precise monitoring of core body temperature without intrusion. A single sensor can accompany a patient from pre-operation through the perioperative period, ensuring seamless tracking. With their non-invasive nature, easy application, and skin-friendly adhesives, wearable sensors enhance comfort and promote longer wear times. These sensors can also store patient data and integrate with monitoring devices, facilitating early detection of elevated temperatures in high-risk patients. This early intervention is crucial for preventing deterioration in clinical outcomes. Continuous temperature monitoring allows healthcare professionals to monitor patients in clinical settings and at home, enabling timely intervention and better clinical results.
Delayed administration of antibiotics can adversely affect mortality rates, underscoring the importance of early fever detection for optimal patient outcomes. In February 2024, the U.S. Patent and Trademark Office published a patent application from Apple regarding a different kind of temperature sensor. Apple acknowledges that while core temperatures can be measured using medical thermometers that access the mouth or ear cavity, these methods are invasive and unsuitable for typical wearable electronic devices like electronic watches.
North America to Dominate Patient Temperature Monitoring Market
North America, notably the United States and Canada, has historically held a prominent position in the global body temperature monitoring market. The region boasts advanced healthcare systems with established institutions that demand state-of-the-art temperature monitoring devices. Additionally, North America serves as a center for medical device innovation, driving continuous advancements in temperature monitoring technology. Stringent regulatory requirements in the United States, including FDA clearance, favor companies with compliant products, further solidifying the region's market influence. Moreover, the population's increasing emphasis on health and wellness, coupled with rising health awareness, drives demand for home-use temperature monitoring devices. The combination of advanced healthcare infrastructure, regulatory approval process, technological innovation, and health-conscious populations creates an environment conducive to the adoption and growth of temperature monitoring devices in North America. Furthermore, ongoing research efforts aimed at developing innovative thermometers are anticipated to propel market growth in the region.
An article published by Frontiers in Medicine in April 2022 highlighted a study conducted to assess the accuracy and precision of a novel, non-invasive Zero-Heat-Flux Thermometer (SpotOn) in patients undergoing targeted temperature management (TTM) post-cardiac arrest at a hospital in Canada. The study concluded that SpotOn offers an accurate method for non-invasive monitoring of core body temperature during TTM.
Future Market Scenario (2024 - 2031F)
Increasing prevalence of various diseases presents the biggest opportunity for the patient temperature monitoring market to rise. High adoption of advanced and effective approaches has been devised to ensure the ease of the user and accuracy while measuring temperature, which presents yet another opportunity in the market. R&D and heavy investments made by big healthcare companies is promoting development in the patient temperature monitoring market, which is anticipated to support the market growth in the future positively. In March 2022, CIRCA Scientific, Inc., a medical device company, announced that its S-CATH M Esophageal Temperature Probe is now cleared by U.S. Food and Drug for sales in the U.S. Successful attempts made towards the betterment of technology also pushes people to further engage with a higher quality of self-care, paving a way for the market to rise.
Key Players Landscape and Outlook
Medical device companies, such as Medtronic PLC, Cardinal Health, Inc, 3M, Becton, Dickinson and Company, Geratherm Medical AG, Braun GmbH, PAUL Hartmann AG, Koninklijke Philips N.V., Microlife Corporation, Dragerwerk AG & Co KGaA, Masimo Corporation, etc. are focusing on new product release, market expansion, and product development. Patient temperature monitoring market participants are poised to encounter promising growth prospects in the global market, driven by the increasing demand for temperature monitors. The primary focus of these leading players is directed towards the rapidly expanding market segment, aiming to thrive in a competitive market environment. Additionally, these market players emphasize collaboration and license agreements as strategic initiatives, which is anticipated to propel market growth.
In December 2022, SmartFuture, a health technology company based in Singapore, introduced a new software development kit designed for remote patient monitoring. This kit can integrate more than 400 regulated wireless medical devices from approximately 40 different brands, such as Omron, Abbott, Roche, and Viacom. These devices encompass various tools for capturing temperature readings and other health data, which are then transmitted through a cloud-based database. This addition expands SmartFuture's range of health technology solutions, which includes a remote patient monitoring platform featuring a mobile application, web portal, wireless medical devices, and electronic medical record (EMR) integrations.
In August 2022, Exergen Corporation announced that NIDEK Medical had entered into a distribution agreement for temporal artery product line, which includes the TAT-5000, TAT-2000, and TAT-2000C Temporal Artery Thermometers, as well as associated accessories, in India.